At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 44 enrolled
Drug / intervention
Ketorolacdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Rotator Cuff Repair
University Hospitals Cleveland Medical Center·interventional·Posted May 30, 2019·Updated May 10, 2022
In Brief
A Phase 3 clinical trial evaluating Ketorolac for Rotator Cuff Tear and Postoperative Pain. Completed, enrolled 44 participants across 1 site.
Detailed Summary
1. The investigators aim to examine the use of IV and oral ketorolac as an adjunctive agent to the standard of care pain protocol for postoperative pain control following arthroscopic rotator cuff repair. 2. The investigators hypothesize that the use of IV and oral ketorolac in addition to the standard of care pain protocol will reduce postoperative opioid consumption following arthroscopic rotator cuff repair.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRotator Cuff Tear, Postoperative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
Enrollment StartFeb 2019
First PostedMay 2019
Primary CompletionOct 2020
Study CompletionMay 2021
TodayJul 2026
First PostedMay 30, 2019
Enrollment StartFeb 11, 2019
Primary CompletionOct 14, 2020
Study CompletionMay 17, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.1 years ago
Interventions
Ketorolacdrug
Oral Ketorolac